World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 27 April 2020
Main ID:  ISRCTN18348009
Date of registration: 15/04/2020
Prospective Registration: Yes
Primary sponsor: University of Valladolid
Public title: Occupational health and safety among health care personnel in a COVID-19 pandemic
Scientific title: Predictive value of biological, physiological and analytical biomarkers with the use of personal protection equipment in COVID-19: observational, prospective, analytical, intervention and multicenter study
Date of first enrolment: 16/04/2020
Target sample size: 80
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN18348009
Study type:  Observational
Study design:  Observational prospective cross-sectional cohort analytical intervention and multicenter study (Prevention)  
Phase:  Not Applicable
Countries of recruitment
Spain
Contacts
Name: Francisco    Martín-Rodríguez
Address:  Facultad de Medicina Avda. Ramón y Cajal, 7 47005 Valladolid Spain
Telephone: +34 686452313
Email: fmartin@saludcastillayleon.es
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. Workers (doctors, nurses and assistants) in the COVID19 treatment unit with the biological risks training course
2. Aged over 18 years
3. Provide informed consent

Exclusion criteria:
1. Pregnant
2. Psychiatric pathology
3. Do not sign the informed consent
4. Not to be part of the HURH and Covid-Fair staff during the month of April


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Complications or secondary effects derived from the use of personal protective equipment against biological risks
Not Applicable
Intervention(s)

Volunteers (workers in a COVID19 treatment unit) undergo a structured and objective evaluation. Physiological variables (respiratory rate, saturation, heart rate, systolic and diastolic blood pressure and temperature) are collected, health variables are also collected (previous illnesses, taking medication, COVID19 symptoms, weight and height) and an analytical test is performed of blood (venous by extraction in the cephalic vein of the left arm) to obtain the following parameters: pH, PaCo2, PO2, HCO3, Na, K, Cl, Ca, Hematocrit, hemoglobin, lactate, glucose, urea, BUN and creatinine.

Volunteers are randomized, some wear N95 respirators and others wear an FFP2 mask with an exhalation valve, are fully equipped with personal protective equipment and enter the COVID19 area. At 4 hours of work they leave, are decontaminated and the same determinations that have been made on a basal basis are repeated. They are also asked if they have a headache (not due to the pressure of the glasses or face shield), wounds or chafing, and how they have felt at the level of tiredness.
At this time, the observation will end.
Primary Outcome(s)

1. Respiratory rate, assessed by clinical observation at baseline and at the end of the 4-hour workday
2. Oxygen saturation, assessed using a Physio LifePAK® 15 monitor at baseline and at the end of the 4-hour workday
3. Heart rate, assessed using a Physio LifePAK® 15 monitor at baseline and at the end of the 4-hour workday
4. Blood pressure, assessed using a Physio LifePAK® 15 monitor at the start of the study and at the end of the 4-hour workday
5. Tympanic temperature evaluated using a Braun ThermoScan® PRO 6000 model at baseline and at the end of the 4-hour workday
6. Weight, with the TANITA BC 545-N scale at baseline
8. Size, with the SECA 206 tape measure at baseline
9. Analytical biomarkers: pH, pCO2, pO2, cHCO3-, BE (ecf), cSO2, Na +, K +, Ca ++, Cl-, TCO2, Agap, AGapK, Hct, Hb, BE (b), Glu , Lac, BUN, Urea and Crea, evaluated using COPD Siemens Healthcare at baseline and at the end of the 4-hour workday
10. Medical history of interest, through a structured questionnaire at baseline
11. Level of physical activity using the IPAQ questionnaire at baseline
Secondary Outcome(s)

1. Headache presence measured using self-report at the end of the 4 hours of working with the equipment
2. Presence of serious adverse events during the use of protective equipment measured using self-report at the end of the 4 hours of working with the equipment
3. Presence of chafing, wounds, etc., due to the use of protective equipment measured using self-report at the end of the 4 hours of working with the equipment
4. Perception of the state of physical fatigue at the end of the working day with the protective equipment measured using self-report at the end of the 4 hours of working with the equipment
5. Time in COVID19 zone measured using self-report at the end of the 4 hours of working with the equipment
Secondary ID(s)
Nil known
V_01_2020_ref.03.v_02
Source(s) of Monetary Support
Investigator initiated and funded
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Approved 10/04/2020, CEIC Área de Salud de Valladolid Oeste (Hospital Universitario Río Hortega, 47012 Valladolid (Valladolid); +34 983 420 400; rconvi@saludcastillayleon.es), ref: PI075-20
Results
Results available:
Date Posted:
Date Completed: 22/04/2020
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history